Onsight Ventures’ Post

Join us next Wednesday at Onsight Insights with Miroslav Gasparek🎙 We welcome Miroslav Gasparek, co-founder and CEO of Sensible Biotechnologies, for the 7th episode of Onsight Insights. Sensible pioneers the next generation of mRNA medicines by transforming living cells into efficient factories that produce mRNA in a scalable and cost-effective manner. Don’t miss out on this chance to explore the next groundbreaking idea. Register now and save the date – July 24, 2024 at 13.00 CET.

Onsight Insights with Manu V Nair! We are excited to welcome Manu V Nair, CEO of Synthara AG, to the next episode of our Onsight Insights series! Zurich-based Synthara aims to become the "Arm of small chips" in the AI era, significantly enhancing devices from wearables to sensors with unmatched efficiency and power. Register now and save the date – August 12, 2024 at 14.00 CET

Onsight Insights with Markus Gstöttner! We are excited to welcome Markus Gstöttner, CEO of clock.bio, to the sixth episode of our Onsight Insights series! Clock.bio, based in Cambridge, is pioneering advancements in cellular reprogramming and the development of therapies to combat age-related diseases. Don’t miss out on this chance to learn from industry leaders and explore groundbreaking ideas. Register now and save the date!

Onsight Insights with Markus Gstöttner! We are excited to welcome Markus Gstöttner, CEO of clock.bio, to the sixth episode of our Onsight Insights series! Clock.bio, based in Cambridge, is pioneering advancements in cellular reprogramming and the development of therapies to combat age-related diseases. Don’t miss out on this chance to learn from industry leaders and explore groundbreaking ideas. Register now and save the date!

Join us next Friday at Onsight Insights 🎙 On the 5th episode of the Onsight Insights series we welcome Alexander Igelmann. Alexander is co-founder and CEO of Lidrotec, a Bochum-based startup at the forefront of semiconductor wafer dicing. We will discuss the future of semiconductor fabrication. Register now and save the date – June 28 at 11:30 CET.

After some technical difficulties last time, we are excited to welcome you this upcoming Monday at Onsight Insight. Dive deep into the future of upstream bioprocessing with Laura Chirica, PhD the CEO of Cellevate. Cellevate AB, based in Sweden, is at the forefront of innovation with their next-generation microcarriers utilizing proprietary nanofiber technology. Their scalable Cellevat3d™ platform provides unparalleled surface area, accurately mimicking the human body's extracellular environment, and is set to revolutionize upstream bioprocessing.

Big news from our portfolio company Black Semiconductor! We are thrilled to share that Black Semiconductor has successfully secured an impressive €254.4 million in their Series A and the IPCEI ME/CT program! This marks one of the largest funding rounds ever for a chip manufacturing company in Europe. 🚀 The investment includes €228.7 million in public funding from the Federal Ministry for Economic Affairs and Climate Action and Ministerium für Wirtschaft, Industrie, Klimaschutz und Energie des Landes NRW, along with €25.7 million in equity investment led by Porsche Ventures and Project A. New investors such as East Hill Equity - Managing Scania Growth Capital, TVF | TechVision Fonds, and NRW.BANK have joined this round, alongside seed investors Vsquared Ventures, Cambium Capital Management, and of course Onsight Ventures. 🌟 We couldn't be more excited about this incredible milestone. Congratulations to Daniel Schall, Sebastian Schall and the entire team at Black Semiconductor on this significant achievement! 👏

Dear Community, we regret to inform you that we had to cancel today's event due to unforeseen technical difficulties. We are working diligently to reschedule the event with Laura Chirica, PhD and will announce the new date and time as soon as possible. Stay tuned for updates!